close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

26.27 -0.69 (-2.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
From STAAR Surgical Company
Via Business Wire
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
From Yunqi Capital Limited
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
 
Via Benzinga
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
From STAAR Surgical Company
Via Business Wire
Shareholder Alert: The Ademi Firm Continues to Investigate Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders
From The Ademi Firm
Via Business Wire
Medical Devices & Supplies - Specialty Stocks Q2 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including STAAR Surgical (NASDAQ:STAA) and its peers. 
Via StockStory
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
From STAAR Surgical Company
Via Business Wire
1 Healthcare Stock with Solid Fundamentals and 2 We Avoid
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
1 Russell 2000 Stock with Exciting Potential and 2 Facing Challenges
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
1 High-Flying Stock to Target This Week and 2 We Avoid
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DAY, WOW, YMAB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
From Brodsky & Smith LLC
Via GlobeNewswire
Predicting the Next Rule Breaker Buyout
Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table? 
Via The Motley Fool
Topics Artificial Intelligence
1 Unpopular Stock That Deserves Some Love and 2 We Brush Off
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Supply Chain
Penumbra, STAAR Surgical, CONMED, Acadia Healthcare, and Select Medical Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
From Brodsky & Smith LLC
Via GlobeNewswire
1 Unprofitable Stock to Consider Right Now and 2 Facing Headwinds
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Shareholder Alert: The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, AMWD, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
This Campbell's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
 
Via Benzinga
STAAR SURGICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of STAAR Surgical Company - STAA
From Kahn Swick & Foti, LLC
Via Business Wire
Beyond The Numbers: 5 Analysts Discuss Staar Surgical Stock
 
Via Benzinga
STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 Numbers
Medical lens company STAAR Surgical (NASDAQ:STAA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 55.2% year on year to $44.32 million. Its GAAP loss of $0.34 per share was 49.9%... 
Via StockStory
Topics Artificial Intelligence
STAAR Surgical (STAA) Q2 Revenue Tops 9%
Via The Motley Fool
Topics Intellectual Property World Trade
STAAR Surgical Co (NASDAQ:STAA) Posts Mixed Q2 2025 Results as China Inventory Cuts Weigh on Revenue
STAAR Surgical reports mixed Q2 2025 results with revenue decline due to China inventory reduction but beats estimates. Ex-China sales grow 10%, and cost cuts improve margins. Stock shows resilience... 
Via Chartmill
STAAR Surgical Reports Second Quarter 2025 Results
From STAAR Surgical Company
Via Business Wire
Why Are STAAR Surgical (STAA) Shares Soaring Today
Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 45.6% in the afternoon session after eye-care company Alcon announced a definitive agreement to acquire the company in an all-cash... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today